Dr_claudia_cort%c3%89s_165_(3).jpg_thumb90

Claudia Paz Cortes Moncada

Profesor Asociado

Universidad de Chile

Santiago, Chile

Líneas de Investigación


HIV/AIDS: clinical epidemiological studies comorbidities: HIV/TB, HIV/Hep B, HIV/cancer PK-PD HIV drugs Transplant Infectious Diseases COVID-19

Educación

  •  Medico Cirujano, UNIVERSIDAD DE CHILE. Chile, 2002
  •  Medicina Interna, UNIVERSIDAD DE CHILE. Chile, 2005
  •  Infectología, UNIVERSIDAD DE CHILE. Chile, 2008

Experiencia Académica

  •   Profesor Asistente Part Time

    UNIVERSIDAD DE CHILE

    Medicina

    Santiago, Chile

    2008 - 2018

  •   Profesor Asociado Part Time

    UNIVERSIDAD DE CHILE

    Medicina

    Santiago, Chile

    2018 - A la fecha

Experiencia Profesional

  •   Profesor Asociado Part Time

    Universidad de Chile

    Santiago, Chile

    2008 - A la fecha

  •   Investigador Other

    Fundacion Arriaran

    Santiago, Chile

    2008 - A la fecha

  •   Medico Staff Part Time

    Clinica Santa Maria

    Santiago, Chile

    2008 - A la fecha

  •   Consultor & Punto Focal Other

    Organización Panamericana de la Salud OPS

    Santiago, Chile

    2021 - A la fecha

  •   Encargada de Investigación Clínica Part Time

    Hospital Clinico San Borja Arriarán

    Santiago, Chile

    2020 - A la fecha

Formación de Capital Humano


Supervisión Tesis de pregrado

2020 Christopher Estay C. Licenciado en Química y Farmacia, Universidad de Santiago. Tesis: Evaluación de la atención farmacéutica a pacientes ambulatorios con VIH/ en el Hospital San Borja Arriarán &
Fundación Arriarán.

Supervisión Tesis de Post grado

2022 Ignacio Leiva, Tesis conducente al grado de Master of Science in Epidemiology, Berlin School of Public Health, Alemania. Relationship between employment status, adherence to antiretroviral
therapy and HIV viral suppression.
2020 Gabriel Castillo. Tesis para optar al grado de Doctor en Ciencia Biomédicas. Universidad de Chile. Description of gut bacteriome composition and its relationship to TH-17/T-REG axis and to inflammatory
markers in Chilean patients living with HIV and viro – immunological discordance.
2020 Alejandro Kral. Tesis conducente al grado de especialista en enfermedades infecciosas, Universidad de Chile. Respuesta virológica al tratamiento en pacientes con VIH que inician ARV con cargas virales
muy altas.
2019 Juan Pablo Carrasco. Máster en Farmacología Clínica. Universidad de Chile. Tesis: Errores de medicación y reacciones adversas a Medicamentos en pacientes con VIH ingresados en un Servicio de
Medicina.
2014 María Fernanda Rodríguez. Tesis conducente al grado de especialista en Medicina Interna, Universidad de Valparaíso. Características clínicas y epidemiológicas de la infección por VIH en
inmigrantes latinoamericanos. Estudio retrospectivo en un centro del Servicio de Salud Metropolitano Central de Santiago en la última década.


Premios y Distinciones

  •   American College of Physicians Exchange fellowship

    AMERICAN COLLEGE OF PHYSICIANS

    Estados Unidos, 2018

    6 semanas de training in Toronto General Hospital en la Unidad de Transplant Infectious diseases

  •   Mejor publicacion Revista Médica de Chile

    SOCIEDAD MEDICA DE SANTIAGO

    Chile, 2019

    Premio Otorgado por la Sociedad médica de Santiago a la mejor publicación realizada en la Revista Médica de Chile en el año 2018. "Evolución de mortalidad, abandono, traslado y retención a corto, mediano y largo plazo en pacientes con infección por VIH: Fundación Arriarán 1990-2015" [Evolution of mortality, retention and loss to follow up of HIV infected subjects followed in a special clinic]

  •   Reconocimiento a la Investigación, Innovación y Creación Artística (VID) Premio Rector Universidad de Chile.

    UNIVERSIDAD DE CHILE

    Chile, 2021

    Reconocimiento a la Investigación, Innovación y Creación Artística (VID) Premio Rector Universidad de Chile.

  •   Distinción 100 mujeres líderes

    Mujeres empresarias

    Chile, 2020

    Distinción 100 mujeres líderes, otorgada por Agrupación Mujeres Empresarias y El Mercurio

  •   Mejor estudio de investigación

    SOCIEDAD CHILENA DE INFECTOLOGIA

    Chile, 2016

    Mejor estudio de investigación. XXXIII Congreso Chileno de Enfermedades Infecciosas: Evolución de la mortalidad, abandono, traslado y retención a corto, mediano y largo plazo de los pacientes con VIH: Fundación Arriarán 1990-2015.

  •   Reconocimiento a la Investigación, Innovación y Creación Artística (VID) Premio Rector Universidad de Chile.

    UNIVERSIDAD DE CHILE

    Chile, 2016

    Reconocimiento a la Investigación, Innovación y Creación Artística (VID) Premio Rector Universidad de Chile.


 

Article (72)

Enteropathy and gut dysbiosis as obstacles to achieve immune recovery in undetectable people with HIV: a clinical view of evidence, successes, and projections
Differential neutralizing antibody responses elicited by CoronaVac and BNT162b2 against SARS-CoV-2 Lambda in Chile.
Tuberculosis treatment intermittency in the continuation phase and mortality in HIV-positive persons receiving antiretroviral therapy.
Antiretroviral therapy and Kaposi's sarcoma trends and outcomes among adults with HIV in Latin America
Disparities in Dolutegravir Uptake Affecting Females of Reproductive Age With HIV in Low- and Middle-Income Countries After Initial Concerns About Teratogenicity
Estimated life expectancy gains with antiretroviral therapy among adults with HIV in Latin America and the Caribbean: a multisite retrospective cohort study
Global estimates of viral suppression in children and adolescents and adults on antiretroviral therapy adjusted for missing viral load measurements: a multiregional, retrospective cohort study in 31 countries
Timing of HIV diagnosis relative to pregnancy and postpartum HIV care continuum outcomes among Latin American women, 2000 to 2017
Hepatitis B and C virus infection among HIV patients within the public and private healthcare systems in Chile: A cross-sectional serosurvey
Increased Mortality After Tuberculosis Treatment Completion in Persons Living With Human Immunodeficiency Virus in Latin America
The HIV epidemic in Latin America: a time to reflect on the history of success and the challenges ahead.
A prospective, multi-center study of Candida bloodstream infections in Chile.
HIV-related tuberculosis: mortality risk in persons without vs. with culture-confirmed disease
The impact of data quality and source data verification on epidemiologic inference: a practical application using HIV observational data
The Population Impact of Late Presentation with Advanced HIV Disease and Delayed Antiretroviral Therapy in Adults Receiving HIV Care in Latin America
[Evolution of mortality, retention and loss to follow up of HIV infected subjects followed in a special clinic].
Early Retention in Care Neither Mediates Nor Modifies the Effect of Sex and Sexual Mode of HIV Acquisition on HIV Survival in the Americas
Early Retention in Care Neither Mediates Nor Modifies the Effect of Sex and Sexual Mode of HIV Acquisition on HIV Survival in the Americas.
Evaluating the care cascade after antiretroviral therapy initiation in Latin America
Evaluating the care cascade after antiretroviral therapy initiation in Latin America.
Evolution of mortality, retention and loss to follow up of HIV infected subjects followed in a special clinic
Is substance use associated with HIV cascade outcomes in Latin America?
Survival after cancer diagnosis in a cohort of HIV-positive individuals in Latin America
Virologic failure and mortality in older ART initiators in a multisite Latin American and Caribbean Cohort
Virologic failure and mortality in older ART initiators in a multisite Latin American and Caribbean Cohort.
A decade of HAART in Latin America: Long term outcomes among the first wave of HIV patients to receive combination therapy
HIV Viral Load Suppression in Adults and Children Receiving Antiretroviral Therapy-Results From the IeDEA Collaboration
HIV Viral Load Suppression in Adults and Children Receiving Antiretroviral Therapy-Results From the IeDEA Collaboration.
Outcomes of HIV-positive patients with cryptococcal meningitis in the Americas
Therapeutic evaluation of prolonged infusions of beta-lactam antibiotics in the treatment and management of critically ill patients
[Evaluation of cardiovascular risk in HIV positive patients in a specialized center at Santiago, Chile].
Assessing the HIV Care Continuum in Latin America: Progress in clinical retention, cART use and viral suppression
Clinical and Virologic Outcomes After Changes in First Antiretroviral Regimen at 7 Sites in the Caribbean, Central and South America Network
Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control ("Three I's") and HIVTuberculosis Service Integration in Lower Income Countries
Substance Use and Adherence Among People Living with HIV/AIDS Receiving cART in Latin America
Time to HAART Initiation after Diagnosis and Treatment of Opportunistic Infections in Patients with AIDS in Latin America
Time to HAART Initiation after Diagnosis and Treatment of Opportunistic Infections in Patients with AIDS in Latin America.
Zika Virus Infection Presenting with Postauricular Lymphadenopathy.
[Clinical and epidemiological characteristics of HIV infection in Latin-American immigrants: comparative analysis from clinical records in a clinical care centre in Santiago in the last decade].
CD4 Response Up to 5 Years After Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in Latin America and the Caribbean.
Clinical and epidemiological characteristics of HIV infection in Latin-American immigrants. Comparative analysis from clinical records in a clinical care centre in Santiago in the last decade
Cluster of Imported Vivax Malaria in Travelers Returning From Peru
Incidence of virological failure and major regimen change of initial combination antiretroviral therapy in Latin America and the Caribbean: an observational cohort study
Monitoring of HIV treatment in seven countries in the WHO Region of the Americas
Temporal Trends in Age at HIV Diagnosis in Cohorts in the United States, the Caribbean, and Central and South America
Tuberculosis in Pediatric Antiretroviral Therapy Programs in Low- and Middle-Income Countries=> Diagnosis and Screening Practices.
Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries
Importance of Legionella pneumophila in the Etiology of Severe Community-Acquired Pneumonia in Santiago, Chile
Use of Third Line Antiretroviral Therapy in Latin America
[Lymphomas associated with HIV infection in patients at the Hospital San Borja Arriarán /Fundación Arriarán 2001-2008, Santiago, Chile].
Correlates of Efavirenz Exposure in Chilean Patients Affected With Human Immunodeficiency Virus Reveals a Novel Association With a Polymorphism in the Constitutive Androstane Receptor
Duration of Anti-Tuberculosis Therapy and Timing of Antiretroviral Therapy Initiation: Association with Mortality in HIV-Related Tuberculosis
Hepatitis B prevalence and influence on HIV treatment outcome and mortality in the Chilean AIDS Cohort
Lymphomas associated with HIV infection in patients at the Hospital San Borja Arriaran/Fundacion Arriaran 2001-2008, Santiago, Chile
Tuberculosis in Antiretroviral Treatment Programs in Lower Income Countries: Availability and Use of Diagnostics and Screening
Control glicémico de pacientes diabéticos hospitalizados en un Servicio de Medicina Interna
Glycemic control in diabetic patients hospitalized in a non-critical care hospital setting
Cancer in HIV-Infected Persons From the Caribbean, Central and South America
Cross-Sectional Analysis of Late HAART Initiation in Latin America and the Caribbean: Late Testers and Late Presenters
Haplotype structure of CYP2B6 and association with plasma efavirenz concentrations in a Chilean HIV cohort
Long-Term Outcomes of a National Expanded Access Program to Antiretroviral Therapy: The Chilean AIDS Cohort
Chilean AIDS cohort. Impact of baseline CD4 count and both, immune recovery and viral suppression at 1 year of first HAART on survival, AIDS defining events and immune recovery reactions
Impact of baseline CD4 count, immune recovery and viral suppression at 1 year of first highly active antiretroviral therapy on survival, AIDS defining events and immune recovery reactions
Impacto de la inmunodepresión basal y su grado de recuperación al año de terapia antirretroviral en sobrevida, complicaciones oportunistas y reacción de recuperación inmune
Cytomegalovirus infections in cardiac transplant patients: An experience at a clinical hospital, University of Chile
Albumin dialysis MARS (Molecular Adsorbent Recirculating System) in acute liver failure, before liver transplantation. Report of three cases
[Community acquired pneumonia. Report of 8 cases of severe pneumonia by serogroup 1 Legionella pneumophila in Chile].
[Intestinal necrosis as clinical presentation of Takayasu arteritis].
Report of eight cases of severe community-acquired pneumonia caused by Legionella in Chile
Assessing the HIV Care Continuum in Latin America: progress in clinical retention, cART use and viral suppression.
Cluster of Imported Vivax Malaria in Travelers Returning From Peru.
Estimated life expectancy gains with antiretroviral therapy among adults with HIV in Latin America and the Caribbean: a multisite retrospective cohort study.

Abstract (4)

Assessing the HIV care continuum in The Caribbean, Central and South America network for HIV epidemiology (CCASAnet): progress in clinical retention, cART use and viral suppression
Major outcomes of early HAART programs at CCASAnet sites: "first wave of HAART" study
Comparison of efavirenz and nevirapine based HAART regimens in 4187 patients with up to 6 years of follow up, a prospective, open label observational study
The Expanded Access Program to HAART in Chile: Baseline Characteristics and Primary Outcomes of Patients Receiving Treatment, Evaluated Through the Chilean AIDS Cohort (ChiAC)

BookSection (1)

Interacciones farmacológicas en VIH

Proyecto (11)

Plataforma informática basada en Inteligencia Artificial para la caracterización e identificación del grado de adherencia al tratamiento para la población con VIH+
A Phase 2b Randomized, Active-Controlled, Double-Blind Trial to Investigate Safety, Efficacy, and Dose-response of BMS-955176, Given on a Backbone of Tenofovir/Emtricitabine, in Treatment-Naive HIV-1 Infected Adults
Diseño y validación de un modelo para la evaluación de la “Cascada de Atención” de la infección por VIH=> desde las políticas de diagnóstico al desempeño de los centros de atención
Utilización de servicios de salud terciaria por inmigrantes latinoamericanos en un centro del Servicio de Salud Metropolitano Central de Santiago.
Infección por virus hepatitis B en pacientes VIH. Estudio multicéntrico de prevalencia de marcadores serológicos
Randomised, Openlabel Study Evaluating Efficacy and Safety of Maraviroc as a Switch for Either NRTI or PI/r in HIV-1 Infected Individuals With Stable, Well‐Controlled Plasma HIV‐RNA While Taking Their First N(t)RTI + PI/r Regimen of cART
Safety and Efficacy of Reduced Dose Efavirenz With Standard Dose EFV Plus Two Nucleotide Reverse Transcriptase Inhibitors in Antiretroviral-naïve HIV-infected Individuals. (encore1)
Strategic Timing of Antiretroviral Treatment (START).
A Randomized, Open-Label, phase II, International Study of Aldesleukin With and Without Concomitant Antiretroviral Therapy (STALWART)
Exploring factors of variability in antiretroviral drug levels in a cohort of Chilean HIV-1 infected patients
International Epidemiologic Database to evaluate AIDS (IeDEA) on Caribbean, Central and South America network for HIV epidemiology (CCASAnet)=>
54
Claudia Cortes

Profesor Asociado

Medicina

Universidad de Chile

Santiago, Chile

9
Marcelo Wolff

Profesor Titular

Medicina

Universidad de Chile

Santiago, Chile

3
Thomas Weitzel

Head Travel Medicine Program

UNIVERSIDAD DEL DESARROLLO

Santiago, Chile

2
Erico Segovia

Medico Nefrologo

Medicina

Hospital Clinico Universidad de Chile

Santiago, Chile

2
Ximena Aguilera

Full Professor; Director Centro de Epidemiología y Políticas de Salud /Center of Epidemiology and Health Policy

Centro de Epidemiología y Políticas de Salud (CEPS)/ Center of Epidemiology and Health Policy/Centro de Epidemiología y Políticas de Salud (CEPS)

Universidad del Desarrollo

Santiago, Chile

1
Maria Eugenia Sanhueza

Medico Nefrologo

Universidad de Chile

Santiago, Chile

1
Lorena Porte

Jefe Sección Microbiología

Laboratorio Clínico

Clínica Alemana

Santiago, Chile

1
María Balcells

Associate Professor

Department of Infectious Diseases of the Adult

Pontificia Universidad Catolica de Chile

Santiago, Chile

1
Alejandro Pacheco

Profesor Asociado, nefrólogo

Medicina Norte

Hospital Clínico Universidad de Chile

Santiago, Chile

1
José Arancibia

sub jefe

unidad de paciente critico

Hospital San Juan de Dios

santiago, Chile

1
José Valera

Médico Gastroenterólogo

Consultorio Adosado de Especialidades

Hospital de La Serena

La Serena, Chile

1
FRANCISCO ARANCIBIA

JEFE SERVICIO MEDICINA RESPIRATORIA

SERVICIO MEDICINA

INSTITUTO NACIONAL DEL TORAX

SANTIAGO, Chile

1
roberto vidal

Head of Pathogenic Escherichia coli Laboratory

Director Microbiology and Mycology Program

UNIVERSIDAD DE CHILE

Santiago, Chile

1
Julia Guerrero

académico

Programa Disciplinario Fisiologia y Biofisica

FACULTAD DE MEDICINA, UNIVERSIDAD DE CHILE

Santiago, Chile

1
Andrés Boltansky

CLINICA DÁVILA

Santiago, Chile

1
Rodrigo Cornejo

Jefe de Servicio

Medicina

UNIVERSAIDAD DE CHILE-HOSPITAL CLINICO UNIVERSIDAD DE CHILE

Santiago, Chile